Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Axonal loss in multiple sclerosis: causes and mechanisms.
[Acid-sensing ion channels as a target for neuroprotection: acidotoxicity revisited].
Terminal complement activation is increased and associated with disease severity in CIDP.
Increased Sleep Depth in Developing Neural Networks: New Insights from Sleep Restriction in Children.
Unilateral olfactory sensitivity in multiple sclerosis.
Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement.
Effect of Platelet-Rich Fibrin on Peripheral Nerve Regeneration.
Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
Cutting Edge: ACVRL1 Signaling Augments CD8α+ Dendritic Cell Development.
Other noninfectious inflammatory disorders.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey.
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
The effect of vibrotactile biofeedback of trunk sway on balance control in multiple sclerosis.
Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.
Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.
14-3-3 proteins regulate K2P 5.1 surface expression on T lymphocytes.
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
Polygenic control of autoimmune peripheral nerve inflammation in rat.
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.
Pages
« first
‹ previous
…
757
758
759
760
761
762
763
764
765
…
next ›
last »